Overall survival and objective response in advanced unresectable hepatocellular carcinoma: A subanalysis of the REFLECT study

By sjmartinez • December 21, 2022

Kudo M, Finn RS, Qin S, Han KH, Ikeda K, Cheng AL, Vogel A, Tovoli F, Ueshima K, Aikata H, López CL, Pracht M, Meng Z, Daniele B, Park JW, Palmer D, Tamai T, Saito K, Dutcus CE, Lencioni R. Overall survival and objective response in advanced unresectable hepatocellular carcinoma: A subanalysis of the REFLECT study. J Hepatol. 2023 Jan;78(1):133-141. doi: 10.1016/j.jhep.2022.09.006. Epub 2022 Sep 20. PMID: 36341767.

Tags: Digestive Diseases, landmark analysis, lenvatinib, mRECIST, Publications, response status, surrogate endpoint

Predicting Pancreatic Ductal Adenocarcinoma Occurrence Up to 10 Years in Advance Using Features of the Main Pancreatic Duct in Pre-Diagnostic CT Scans

Wang L, Shi Y, Qureshi TA, Xie Y, Gaddam S, Azab L, Wu C, He Y, Deng Z, Javed S, Diwan G, Vendrami CL, Rodriguez[...]

Targeting the interaction between long noncoding RNA XR_001779380 and Prdm1 to enhance IFN-γ immunity in murine neonatal intestinal epithelial cells

Jin K, Gong A-Y, Wang S, Martins GA, Strauss-Soukup JK, O'Connor RM, Chen X-M. Targeting the interaction between long noncoding RNA XR_001779380 and Prdm1 to[...]

Tumoral Melanosis of the Colon: A Rare Manifestation of Regressed Melanoma

Dua A, Narasimhalu T, Hamidi S, Dewan R, Nulsen B. Tumoral Melanosis of the Colon: A Rare Manifestation of Regressed Melanoma. ACG Case Rep J.[...]